BUSINESS TCM product approved for sale in Singapore

BUSINESS

TCM product approved for sale in Singapore

China Daily

16:21, May 07, 2020

Information on Lianhua Qingwen capsules on the website of Health Sciences Authority of Singapore. (Photo provided to chinadaily.com.cn)

Lianhua Qingwen, a recommended medicine for treating patients with mild COVID-19 symptoms, has been approved as a Chinese proprietary medicine by the Health Sciences Authority in Singapore.

The designation means the product can be sold in the country as a medicine, the drug's manufacturer said on Wednesday.

Made by Shijiazhuang Yiling Pharmaceutical Co, in Shijiazhuang, Hebei province, the medicine meets Singapore's standards for registration as a Chinese patent medicine, it said.

The capsule, a traditional Chinese medicine used in the treatment of influenza, has been approved for sale as a medicine, food supplement or natural health product in a dozen countries and regions, including Brazil, Romania, Thailand and Ecuador. It can also be sold in the Hong Kong and Macao special administrative regions.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue